purine has been researched along with cladribine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Józefowicz-Okonkwo, G; Robak, T; Szmigielska-Kapłon, A | 1 |
| Lamanna, N; Weiss, M | 1 |
| Epner, EM; Phillips, JD; Spurgeon, S; Yu, M | 1 |
| Polliack, A; Tadmor, T; Tam, CS | 1 |
2 review(s) available for purine and cladribine
| Article | Year |
|---|---|
Purine analogs in leukemia.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia; Pentostatin; Purines; Stem Cell Transplantation; Vidarabine | 2004 |
Cladribine: not just another purine analogue?
Topics: Adenosine Deaminase Inhibitors; Antineoplastic Agents; Autoimmune Diseases; Cladribine; Clinical Trials as Topic; DNA Methylation; Humans; Molecular Structure; Neoplasms; Purines | 2009 |
2 other study(ies) available for purine and cladribine
| Article | Year |
|---|---|
Cytotoxic effect of cyclosporin A alone and in combination with 2-chlorodeoxyadenosine against P388 murine leukemia in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclosporine; Drug Synergism; Immunosuppressive Agents; Male; Mice; Neoplasm Transplantation; Neoplasms; Purines; Time Factors; Tumor Cells, Cultured | 2002 |
The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: are all purine analogs created equal?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Clinical Trials, Phase II as Topic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplastic Stem Cells; Purines; Rituximab; Treatment Outcome | 2010 |